SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ALLON THERAPEUTICS INC
(NQPK:NPCUF Last Sale: .0003 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details


NQPK: (NPCUF : $.0003)
$0 million Market Cap at September 11, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today
Vancouver, BC Research Report Earnings Snapshot - Last
Canada


Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon’s lead drug, davunetide, is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).
Historical Charts    Technical Analysis
No Historical Data available for NPCUF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common NPCUF $.0003 $ 0 $.0003 $.0003 2,451,000 $.0001 $.525 140,556
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $42

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex